Standout Papers

The Cochrane Collaboration's tool for assessing risk of bias in randomised ... 2007 2026 2013 2019 25.4k
  1. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)
    Julian P. T. Higgins, Doug Altman et al. BMJ
  2. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. PLoS Medicine
  3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)
    Erik von Elm, Douglas G. Altman et al. PLoS Medicine
  4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)
    A. Liberati, Doug Altman et al. BMJ
  5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)
    Erik von Elm, Douglas G. Altman et al. Annals of Internal Medicine
  6. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)
    Erik von Elm, Douglas G. Altman et al. The Lancet
  7. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2008)
    Erik von Elm, Douglas G. Altman et al. Journal of Clinical Epidemiology
  8. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Journal of Clinical Epidemiology
  9. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Annals of Internal Medicine
  10. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies (2014)
    Erik von Elm, Douglas G. Altman et al. International Journal of Surgery
  11. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)
    David Moher, Sally Hopewell et al. BMJ
  12. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)
    Jan P. Vandenbroucke, Erik von Elm et al. PLoS Medicine
  13. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)
    Erik von Elm, Douglas G. Altman et al. BMJ
  14. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015)
    Brian Hutton, Georgia Salanti et al. Annals of Internal Medicine
  15. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials (2013)
    An‐Wen Chan, Jennifer Tetzlaff et al. Annals of Internal Medicine
  16. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013)
    A.-W. Chan, Jennifer Tetzlaff et al. BMJ
  17. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Italian Journal of Public Health
  18. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies (2007)
    Erik von Elm, Douglas G. Altman et al. Preventive Medicine
  19. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) (2007)
    Jan P. Vandenbroucke, Erik von Elm et al. Epidemiology
  20. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration (2014)
    Jan P. Vandenbroucke, Erik von Elm et al. International Journal of Surgery
  21. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials (2011)
    David Moher, Sally Hopewell et al. International Journal of Surgery
  22. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)
    David Moher, Sally Hopewell et al. Journal of Clinical Epidemiology
  23. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2007)
    Erik von Elm, Douglas G. Altman et al. Epidemiology
  24. Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials (2004)
    An‐Wen Chan, Asbjørn Hróbjartsson et al. JAMA
  25. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies* (2007)
    Erik von Elm, Douglas G. Altman et al. Bulletin of the World Health Organization
  26. Is the Placebo Powerless? (2001)
    Asbjørn Hróbjartsson, Peter C Gøtzsche New England Journal of Medicine
  27. Screening for breast cancer with mammography (2013)
    Peter C Gøtzsche, Karsten Juhl Jørgensen Cochrane Database of Systematic Reviews
  28. Increasing value and reducing waste: addressing inaccessible research (2014)
    An‐Wen Chan, Fujian Song et al. The Lancet
  29. Placebo interventions for all clinical conditions (2010)
    Asbjørn Hróbjartsson, Peter C Gøtzsche Cochrane Database of Systematic Reviews
  30. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts (2013)
    Elaine Beller, Paul Glasziou et al. PLoS Medicine
  31. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials (2023)
    Daniela R. Junqueira, Liliane Zorzela et al. BMJ

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 61 standout
Sub-graph 1 of 18

Citing Papers

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
2021 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
10 intermediate papers

Works of Peter C Gøtzsche being referenced

Overdiagnosis in organised mammography screening in Denmark. A comparative study
2009
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
2009
and 7 more

Author Peers

Author Last Decade Papers Cites
Peter C Gøtzsche 9159 18413 24974 39970 25014 276 196.6k
Matthias Egger 8665 19445 24340 35836 31896 751 204.3k
Julian P. T. Higgins 9063 15144 16645 31545 21573 446 178.4k
Alessandro Liberati 4985 13748 23493 33889 21926 84 187.2k
John P. A. Ioannidis 18083 12956 20022 25317 17450 1.1k 180.8k
Gordon Guyatt 12338 9155 23232 32454 22197 1.3k 166.8k
Stuart Pocock 4901 9393 13808 31770 16294 569 137.2k
Jennifer Tetzlaff 7161 20059 32288 49346 31669 40 265.9k
Mike Clarke 6379 11504 15038 21439 12159 582 119.1k
Jan P. Vandenbroucke 3027 8818 14038 21047 15026 439 107.2k
George Davey Smith 2580 11929 31623 22578 25688 2.0k 209.0k

All Works

Loading papers...

Rankless by CCL
2026